M2 Pharma - Policy and Regulations

Arcus Biosciences enters clinical trial collaboration with Bristol Myers Squibb in kidney cancer programme

3 June 2026 - Clinical-stage biopharmaceutical company Arcus Biosciences Inc (NYSE:RCUS) announced on Wednesday that it has entered into a clinical trial collaboration and supply agreement with biopha...

Evogene completes Phase 1 study of BMC128 in combination with Nivolumab

3 June 2026 - Computational chemistry company Evogene Ltd (Nasdaq:EVGN) (TASE:EVGN) announced on Tuesday the successful completion of the first-in-human (FIH) Phase 1 clinical study of BMC128, a ratio...

Cumberland Pharmaceuticals and Vanderbilt Health report data from Phase 2a trial of ifetroban to prevent cancer metastasis

3 June 2026 - Specialty pharmaceutical company Cumberland Pharmaceuticals Inc (Nasdaq:CPIX) and healthcare provider Vanderbilt Health on Tuesday announced data from a Phase 2a clinical trial of ifetro...

First Foundation Labs partners with Microsoft to bring AI-powered clinical and translational reasoning to Microsoft Discovery

3 June 2026 - First Foundation Labs (1FL), a life sciences AI company spun out of Luma Group, announced on Tuesday a collaboration with Microsoft (NASDAQ:MSFT) to accelerate the development and enterp...

FDA accepts Genentech's giredestrant application for early-stage breast cancer

2 June 2026 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), said on Tuesday that the US Food and Drug Administration (FDA) has accepted its New Drug Appli...

Ansun Biopharma reports positive recommendation from independent DMC for DAS181

2 June 2026 - Clinical-stage biopharmaceutical company Ansun Biopharma Inc announced on Monday that its independent Data Monitoring Committee (DMC) has issued a positive recommendation following a pre...